Literature DB >> 2561955

Human glioblastoma cell lines have neuropeptide receptors for bombesin/gastrin-releasing peptide.

T W Moody1, S Mahmoud, J Staley, L Naldini, D Cirillo, V South, S Felder, R Kris.   

Abstract

Bombesin/gastrin-releasing peptide receptors were characterized in human glioblastoma cell lines. [125I]Gastrin-releasing peptide or ([125I]Tyr4)bombesin bound with high affinity to these cell lines. Binding to cell line U-118 was time dependent, reversible, and specific. ([125I]Tyr4)Bombesin bound with high affinity (Kd = 1.6 nM) to a single class of sites (Bmax = 30,000/cell). The C-terminal of bombesin- or gastrin-releasing peptide was essential for high-affinity binding. Bombesin- or gastrin-releasing peptide elevated the cytosolic Ca2+ levels in a dose-dependent manner. Because gastrin-releasing peptide, but not gastrin-releasing peptide, increased the cytosolic Ca2+ levels, the C-terminal but not the N-terminal of GRP is essential for biological activity. These data indicate that biologically active bombesin receptors are present in human glioblastoma cell lines.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2561955

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  7 in total

1.  Gastrin-Releasing Peptide Receptor Knockdown Induces Senescence in Glioblastoma Cells.

Authors:  Pâmela Rossi Menegotto; Patrícia Luciana da Costa Lopez; Bárbara Kunzler Souza; Caroline Brunetto de Farias; Eduardo Cremonese Filippi-Chiela; Igor Araújo Vieira; Gilberto Schwartsmann; Guido Lenz; Rafael Roesler
Journal:  Mol Neurobiol       Date:  2016-01-16       Impact factor: 5.590

2.  Solubilization and purification of bombesin/gastrin releasing peptide receptors from human cell lines.

Authors:  J Staley; D H Coy; R T Jensen; T W Moody
Journal:  J Mol Neurosci       Date:  1993       Impact factor: 3.444

3.  Anti-proliferative effect of the gastrin-release peptide receptor antagonist RC-3095 plus temozolomide in experimental glioblastoma models.

Authors:  Marianne Schrader de Oliveira; Giovana Cechim; Elisandra Braganhol; Daniel Garcia Santos; Luise Meurer; Cláudio Galvão de Castro; Algemir Lunardi Brunetto; Gilberto Schwartsmann; Gilberto Schwarstmann; Ana Maria Oliveira Battastini; Guido Lenz; Rafael Roesler
Journal:  J Neurooncol       Date:  2009-01-08       Impact factor: 4.130

4.  Effective treatment of experimental U-87MG human glioblastoma in nude mice with a targeted cytotoxic bombesin analogue, AN-215.

Authors:  Z Szereday; A V Schally; A Nagy; A Plonowski; A M Bajo; G Halmos; K Szepeshazi; K Groot
Journal:  Br J Cancer       Date:  2002-04-22       Impact factor: 7.640

Review 5.  Bombesin Receptor Family Activation and CNS/Neural Tumors: Review of Evidence Supporting Possible Role for Novel Targeted Therapy.

Authors:  Terry W Moody; Lingaku Lee; Irene Ramos-Alvarez; Tatiana Iordanskaia; Samuel A Mantey; Robert T Jensen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-01       Impact factor: 5.555

6.  A vasoactive intestinal peptide antagonist inhibits the growth of glioblastoma cells.

Authors:  A Sharma; J Walters; Y Gozes; M Fridkin; D Brenneman; I Gozes; T W Moody
Journal:  J Mol Neurosci       Date:  2001-12       Impact factor: 3.444

7.  Gastrin-releasing peptide receptors in the central nervous system: role in brain function and as a drug target.

Authors:  Rafael Roesler; Gilberto Schwartsmann
Journal:  Front Endocrinol (Lausanne)       Date:  2012-12-17       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.